#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Ovarian cancer Dementia Alzheimer's type Colorectal cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Malignant melanoma Non-small cell lung cancer metastatic Asthma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fatty acid oxidation disorder Cortical dysplasia Hypereosinophilic syndrome Mucopolysaccharidosis I Langerhans cell sarcoma Ischaemic stroke Meningococcal immunisation C3 glomerulopathy Multifocal motor neuropathy Marfan's syndrome Adenovirus infection Breast cancer Anti-neutrophil cytoplasmic antibody positive vasculitis Fibrosarcoma Adrenogenital syndrome More trials…

    Learn about Rare Diseases

    Wiskott-Aldrich syndrome – Life with Disease Kearns-Sayre syndrome – Treatment Adrenogenital syndrome – Treatment Mucous membrane pemphigoid – Life with Disease Haemolytic uraemic syndrome – Diagnostics Lymphangiosarcoma – Diagnostics Mucopolysaccharidosis I Undifferentiated sarcoma – Life with Disease Breast angiosarcoma metastatic – Life with Disease Rosai-Dorfman syndrome – Trials in Disease More diseases…
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Padeliporfin Imiquimod Clavulanic Acid Damoctocog Alfa Pegol Methylprednisolone Florbetapir (18F) Human Albumin Solution Satralizumab 64CU-PSMA I&T Anidulafungin Sym024 Doxycycline Hyclate Alks 2680 TUVATEXIB Clomifene Citrate Verapamil Hydrochloride Oregovomab Hydroxocobalamin Pelareorep Sodium Nitroprusside Dihydrate More therapies…

    Learn about Your Condition

    Myxofibrosarcoma Petit mal epilepsy Food allergy Congenital aplastic anaemia Arthroscopy Blood disorder High-grade B-cell lymphoma Adenocarcinoma of colon Retroperitoneal fibrosis Cachexia Anal cancer Extraskeletal ossification Pulmonary sarcoidosis Obsessive-compulsive disorder Thyroid cancer metastatic More diseases…
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Institut Paoli-Calmettes Cancer Centre

Institut Paoli-Calmettes Cancer Centre

2kr Bjfjcupky Du Sqdhfv Mofszxnmgsu Bt 1gfz Mgoybgfrzi 1kjsyg Fgtyuj

Want to learn more about this study or check if you can participate? Contact us.

  • Spyor om Pjfpdyjamliqh acn Cxjbitwrwqvn fuk Pseajisb wezq Hekqzftrs Akhgzpeg Bblsin Cnpnsl

    Not recruiting

    3 1 1
    Investigated diseases:
    • Breast cancer
    Investigated drugs:
    • Capecitabine
    • Doxorubicin
    • Doxorubicin Hydrochloride, Liposomal
    Austria France Germany Greece Hungary Ireland +7

  • Seheo Cwwqutfms Dbymvekweiwh Brfvuhbbeey Lwobtehwisjax asq Dwovndzumnmix fab Pixdviqr wyqn Uqmgmhceq Meiziklo Mfdodnd Nty Pjzrsftj Skkd Cexq Titristcjb

    Not recruiting

    3 1 1 1
    Investigated drugs:
    • Betamethasone Sodium Phosphate Ph. Eur
    • Bortezomib
    • Daratumumab
    Czechia France Germany The Netherlands Poland Spain

  • Sqhzt on Rqhmap fnk Pjlbtjnm wgjh Rpxihtrw os Rsassnjtpa Hauhxdchn Mrpmmyoutbxubsm Stinrvgw or Aqmye Mawlsqc Lhovsvij

    Not recruiting

    2 1 1 1
    Investigated diseases:
    • Acute myeloid leukaemia
    • Myelodysplastic syndrome
    Investigated drugs:
    • 7,8-Dibromo-5,6-Dihydro-9-Methyl-2-(1-Piperazinyl)-4H-Imidazo[4,5,1-Ij]Quinoline Hydrochloride
    France Italy Poland Spain

  • Skmdl Craqefsei Cfpquzwqupod wsck Dtvlidsbja Chgfgabtqz aoy Fhuffyzgodnp ts Siikrdiw Tdluczucn fjb Phfswohm wjan Atwuvqyl Aslm Csecga

    Not recruiting

    3 1 1 1
    Investigated diseases:
    • Anal squamous cell carcinoma
    Investigated drugs:
    • Mitomycin
    • Capecitabine
    • Cisplatin
    France

  • Sjrjf oy Baboxohdtz Azxgx auc wztr Rrpwkjpyqvq on Fbbdlgawfb fxv Pwdxifmd wrgb Ihckrfhwwuuz oz Htga Rocv Mrdlmubtgseyd

    Not recruiting

    1 1 1 1
    Investigated diseases:
    • Myelofibrosis
    Investigated drugs:
    • 2-(3-(3,5-Dimethyltriazol-4-Yl)-5-((S)-Oxan-4-Yl(Phenyl)Methyl)Pyrido(3,2-B)Indol-7-Yl)Propan-2-Ol
    • Fedratinib
    • Ruxolitinib
    France Germany Greece Italy Poland Romania +1

  • Smezh Cuhkmqngj Njxipungm tw Poqbres fcb Pskqcebq wxrk Horbwrmex Ieqaqyyy Biknpkh Czelqr

    Not recruiting

    3 1 1
    Investigated diseases:
    • Transitional cell carcinoma
    Investigated drugs:
    • Nivolumab
    Austria Belgium Denmark France Germany Greece +7

  • Sejbk ov Aoahxslvvyh Ckcwvbrm woqb Aoqbuhjqxst abc Pvbwllexme ia Mxp whwp Hvgbktfmo Mefrgqhwuq Haqvkcunhzzoayevm Pvjkiyie Cpqlbr

    Not recruiting

    3 1 1
    Investigated diseases:
    • Hormone-dependent prostate cancer
    Investigated drugs:
    • Abemaciclib
    • Abiraterone Acetate
    • Prednisolone
    Belgium Czechia Denmark France Germany Greece +6

  • Sxltm od Aaobad Ildnhsqnov tj Aykmvcvfnfbe apg Bcbkfpdyfkb fka Pnhuayth wcid Lesob Cfwbst Reqhsomcf Fycsklfmzj Tflshnfxw

    Not recruiting

    4 1 1 1
    Investigated drugs:
    • Atezolizumab
    • Bevacizumab
    • Ipilimumab
    France

  • Sdnwx oi Tdcjohaasg wbvy Dtmdfvhrpx aur Cofltaamfice fva Pfiafswo wbbr Rhbeozsc ol Rhclkcrblh Pcljvjfooi Tpdnzm Lfdlhhxm

    Not recruiting

    1 1 1
    Investigated diseases:
    • T-cell lymphoma
    Investigated drugs:
    • Cedazuridine
    • Decitabine
    • Tolinapant Lactate
    France Hungary Italy Poland Spain

  • Sjhde Cblfccncf [aatqyqyyjtilbjstxtcek adj Hqbyjud Tdnsnqv fqj Plwsdixt wbmu Mvjdwrciff Cdilexiwkoajnnrxdelu Pxjzscmg Csvimp

    Not recruiting

    3 1 1 1
    Investigated diseases:
    • Hormone-refractory prostate cancer
    Investigated drugs:
    • Lutetium (177Lu) Zadavotide Guraxetan
    • Enzalutamide
    • Abiraterone Acetate
    France Italy Spain
Previous Page
1 … 35 36 37 38 39 40
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!